Afuco™ Anti-Human DCBLD2 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-DCBLD2 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. This is a novel antibody capable of recognizing an extracellular domain of a human CLCP1 antigen; it can be used for the treatment or prevention of cancer.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-195CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | DCBLD2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at 4°C for up to 3 months. For longer term storage aliquot into small volumes and store at -20°C. |